Study endpoints
The primary endpoint was the occurrence of the composite of aortic valve
intervention (including AVR or TAVR) or all-cause mortality between
baseline and last follow-up. The secondary endpoints were the occurrence
of cardiovascular mortality and AVR/TAVR between baseline and last
follow-up.